If you’ve been exploring treatment options for depression, anxiety or another psychiatric or neurological condition, you may be wondering whether transcranial magnetic stimulation (TMS) therapy is right for you.
TMS is a non-invasive form of brain stimulation that may be considered when symptoms persist despite other approaches. But TMS candidacy isn’t determined by diagnosis alone. Your symptoms, treatment history, medications, medical history, safety considerations and individual clinical needs can all play a role.
At Neurotherapeutix, we take that evaluation a step further by using functional brain imaging and computational brain mapping to understand how networks throughout your brain communicate before fMRI-guided TMS therapy begins.
Quick answer: Am I a candidate for TMS therapy?
You may be a candidate for TMS therapy if you have a psychiatric or neurological condition that may respond to brain stimulation, particularly when symptoms have persisted despite medication, psychotherapy or other treatment.
Eligibility also depends on your medical history and whether TMS therapy can be performed safely.
At Neurotherapeutix, a clinical evaluation helps determine whether treatment is appropriate for you and how our fMRI-guided approach may fit your individual needs.
What is transcranial magnetic stimulation therapy?
Transcranial magnetic stimulation is a non-invasive treatment that uses magnetic pulses to stimulate targeted areas of the brain. Unlike electroconvulsive therapy (ECT), TMS does not require anesthesia or induce a seizure as part of treatment.
You remain awake during the session while a magnetic coil positioned against your scalp delivers repeated magnetic pulses to the treatment target. Most patients can return to their usual activities afterward.
How TMS therapy works
TMS therapy uses a rapidly changing magnetic field to induce a small electrical current in targeted brain tissue. Repeated stimulation can influence activity within brain networks involved in mood, cognition and other functions.
The specific area targeted, stimulation pattern and treatment protocol depend on the condition being treated and the type of TMS approach being used.
Standard TMS vs. fMRI-guided TMS therapy
Standard TMS therapy typically identifies treatment targets using standardized anatomical measurements or scalp-based landmarks.
At Neurotherapeutix, fMRI-guided TMS therapy takes a different approach.
Resting-state functional magnetic resonance imaging (rsfMRI) measures patterns of activity and communication across functional networks throughout your brain.
Our patented computational brain mapping technology analyzes those connectivity patterns to identify individualized areas of interest based on your functional brain organization.
Those findings are uploaded into the neuronavigation software, which helps the treatment team precisely identify and target the individualized brain regions during therapy.
Rather than relying only on a standard treatment location, this whole-brain approach lets treatment planning reflect how your individual brain functions.
FDA-cleared TMS therapy for mental health
TMS has been FDA-cleared for specific indications, including major depressive disorder and obsessive-compulsive disorder (OCD). Different TMS devices and protocols have received clearance for different indications and patient populations.
At Neurotherapeutix, candidacy is determined through an individualized clinical evaluation.
When considering TMS for conditions or circumstances outside a particular FDA-cleared indication, your treatment team can discuss the available evidence and whether treatment may be clinically appropriate.
Am I a candidate for fMRI-guided TMS therapy? Key signs to look for
There is no single checklist that determines whether someone qualifies for TMS therapy. However, you may want to explore an evaluation if:
- Your symptoms have persisted despite previous treatment.
- Medication has not provided sufficient relief or has caused difficult side effects.
- Psychotherapy or other interventions have not provided the improvement you hoped for.
- You are interested in a non-invasive brain stimulation option.
- You have previously received standard TMS and are exploring a more individualized targeting approach.
- You want treatment planning informed by your individual functional brain activity rather than diagnosis alone.
For depression specifically, TMS therapy is commonly considered when symptoms have not adequately responded to antidepressant treatment. If you have experienced multiple unsuccessful treatment attempts, learn more about treatment-resistant depression and the treatment options that may be considered.
These factors do not automatically mean TMS is appropriate for you. Your clinical and medical history still needs to be reviewed before treatment is recommended.
Who can get fMRI-guided TMS therapy?
TMS therapy may be considered for people experiencing a range of psychiatric and neurological symptoms, depending on their diagnosis, treatment history and individual clinical circumstances.
At Neurotherapeutix, our team evaluates the whole clinical picture rather than determining candidacy from diagnosis alone.
For example, someone exploring TMS therapy for depression may have persistent symptoms despite antidepressant medication or psychotherapy.
Someone seeking treatment for anxiety may have a different symptom pattern, treatment history and functional connectivity profile.
Neurotherapeutix also evaluates patients with other psychiatric and neurological conditions when TMS may be clinically appropriate.
The first question is therefore not simply: What is your diagnosis? It is: What has your individual experience with that condition looked like, and what does your clinical evaluation tell us about the next appropriate step?
Is fMRI-guided TMS therapy right for me? Important questions to consider
Deciding whether TMS therapy is appropriate starts with understanding your symptoms, previous treatments, medical history and goals.
If you have already tried standard TMS therapy, your treatment team will also want to understand which protocol was used, how treatment was targeted and how you responded.
A previous lack of response does not necessarily mean that fMRI-guided TMS will not be effective. Standard TMS typically uses a standardized, one-size-fits-all approach to identify treatment locations. Rather than mapping each individual’s brain organization, clinicians may position the coil using external scalp landmarks, such as the 5-cm rule.
Because brain anatomy and functional networks vary from person to person, this approach may not always identify the most relevant treatment target for every patient.
Functional brain imaging can provide additional information about an individual’s brain organization. Clinicians may consider this information when evaluating treatment options and developing a more personalized treatment approach.
How will TMS therapy work for me?
No clinician can predict exactly how an individual patient will respond to TMS therapy before treatment begins.
At Neurotherapeutix, we use your clinical evaluation and computational brain mapping to individualize treatment planning and targeting. We then monitor your response throughout care so your team can evaluate your progress.
Treatment length and session duration depend on the protocol selected for you. TMS therapy is performed without anesthesia or sedation, and most patients can return to their usual activities following treatment.
Do I need to stop medication before TMS therapy?
Not necessarily.
TMS therapy may be used alongside medication and other forms of mental health treatment. You should not stop or change a prescribed medication on your own before beginning TMS.
Your treatment team will review your medications as part of the evaluation because certain medications or medication changes may affect treatment planning or seizure risk. Any changes should be made in consultation with the clinician managing your medication.
Who is not eligible for TMS therapy?
Certain medical devices, implants or health considerations may make TMS therapy inappropriate or require additional safety evaluation.
Your treatment team will ask about factors such as:
- Implanted metallic or electronic devices in or near the head
- Cochlear implants or certain other implanted hearing devices
- A history of seizures or conditions that may affect seizure risk
- Neurological or medical conditions relevant to treatment safety
- Medications that may affect seizure threshold
Not every item on this list automatically excludes someone from treatment. The type and location of an implant, your medical history and other clinical factors matter.
That is why safety screening is essential to determining TMS therapy candidacy.
Safety guidelines and side effects
fMRI-guided TMS therapy is non-invasive and does not require surgery, anesthesia or sedation.
The most common side effects are generally temporary and may include headache, scalp discomfort or sensations at the treatment site. Some people may also experience facial muscle twitching during stimulation.
Seizure is a rare but serious potential adverse effect of TMS therapy. For this reason, your medical history, medications, sleep patterns, and other factors that may affect seizure risk are carefully reviewed before treatment begins. When delivered within established safety guidelines, the risk of a TMS-associated seizure is very low.
For some individuals with epilepsy, certain rTMS approaches are being studied or used in specialized clinical and research settings to modulate brain excitability and potentially reduce seizure frequency. However, TMS for epilepsy is not appropriate for every person and should be considered only after individualized medical evaluation, with careful treatment planning and monitoring by clinicians experienced in both TMS and seizure disorders.
Your Neurotherapeutix team will discuss the risks and benefits that apply to your specific treatment plan before you begin therapy.
What to expect from fMRI-guided TMS therapy treatment
At Neurotherapeutix, treatment begins before the first magnetic pulse is delivered.
1. Clinical evaluation
Your team reviews your symptoms, diagnoses, medical history, medications, previous treatments and treatment goals.
2. Resting-state fMRI
Your brain is scanned while you are at rest so patterns of activity and communication across functional brain networks can be measured.
3. Computational brain mapping
Our patented technology analyzes your functional connectivity data to identify individualized areas of interest that may inform treatment targeting.
4. Treatment planning
Your imaging findings and clinical evaluation are considered together to develop an individualized treatment plan.
5. fMRI-guided TMS therapy
Neuronavigation helps your treatment team consistently locate your individualized treatment target as magnetic stimulation is delivered.
6. Monitoring
Your clinical response is monitored throughout treatment, allowing your team to evaluate progress and determine appropriate next steps.
Why choose Neurotherapeutix in NYC for fMRI-guided TMS therapy
Neurotherapeutix is the only clinic in the United States offering its patented fMRI-guided TMS therapy.
From our Upper East Side clinic in Manhattan, our multidisciplinary team brings together neuroscience, MRI physics, psychiatry and clinical expertise to understand your symptoms through the lens of your individual brain function.
Rather than determining treatment location from diagnosis alone, our approach combines whole-brain functional imaging, computational analysis, individualized targeting and neuronavigation to personalize treatment.
Frequently asked questions about TMS therapy eligibility and treatment
Can TMS therapy help if medications haven’t worked?
TMS therapy may be considered for people with depression when symptoms have not improved sufficiently with antidepressant medication, psychotherapy, or other appropriate treatments. Persistent symptoms despite adequate treatment trials are a common reason people explore TMS as a noninvasive treatment option.
However, medication history is only one part of determining candidacy. Your diagnosis, symptoms, medical history, previous treatments and safety considerations should all be evaluated.
Large studies such as the National Institute of Mental Health STAR*D study have also demonstrated that achieving remission can become more difficult after multiple unsuccessful medication treatment steps, highlighting the need for additional treatment options for people with persistent depression.
Is TMS therapy painful or uncomfortable?
TMS therapy does not require anesthesia, but you can feel the stimulation.
Patients commonly describe a tapping or pulsing sensation on the scalp during treatment. Temporary scalp discomfort or headache can occur, particularly during early sessions.
Your treatment team can discuss what to expect and address discomfort if it occurs.
How long do TMS treatment results last?
There is no single duration that applies to every patient.
How long improvement lasts can vary according to the individual, condition, treatment response and other clinical factors. Neurotherapeutix follows patients after an acute course of fMRI-guided TMS therapy at approximately one, three and six months.
Following completion of an fMRI-guided TMS treatment course, patients undergo a follow-up fMRI scan to compare post-treatment findings with their baseline imaging. This comparison helps objectively assess treatment-related changes and guides recommendations for the next phase of care.
The follow-up fMRI, together with the patient’s clinical response, may help determine whether maintenance or additional treatment sessions should be considered. If symptoms return, the care team may recommend a clinical reassessment and, when appropriate, additional functional imaging to evaluate changes in brain connectivity and inform whether booster treatment or an updated treatment plan may be beneficial.
Are there age limits for TMS therapy?
Age is one consideration in determining whether TMS is appropriate, but candidacy should be based on the complete clinical picture.
FDA clearances for TMS vary by device, indication and age group. Neurotherapeutix evaluates each patient individually to determine whether treatment is clinically appropriate and to discuss the evidence, potential benefits and risks relevant to that patient.
Does Neurotherapeutix work with my insurance?
Neurotherapeutix is a private-pay practice. We do not submit claims, call insurance companies, or handle insurance matters on behalf of patients. Instead, we provide clear visit summaries, medical records, reports, and billing codes so that you can submit a claim to your insurance on your own if you choose.
How is candidacy different with fMRI-guided brain mapping vs. standard TMS therapy?
The fundamental safety considerations for TMS still apply whether treatment uses standard or fMRI-guided targeting.
The difference is how Neurotherapeutix evaluates your individual brain function and determines where stimulation should be delivered.
Standard TMS typically uses standardized anatomical measurements or scalp-based landmarks to identify a treatment location.
At Neurotherapeutix, resting-state fMRI and computational brain mapping provide information about functional connectivity across your individual brain. Those findings can then inform individualized treatment targets and planning.
Brain mapping does not guarantee that you are a candidate or that you will respond to treatment. Instead, it gives the clinical team additional individualized information to consider when determining whether and how fMRI-guided TMS may fit into your care.
Find out whether fMRI-guided TMS therapy may be right for you
You do not have to determine TMS therapy candidacy on your own.
If symptoms have continued despite previous treatment, or you want to understand whether an individualized brain stimulation approach may be appropriate, our team can review your history, answer your questions and help you understand your options.
Prefer to speak with our team first? Contact us directly or call (917) 388-3090.
